nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosaprepitant—TACR1—asthma	0.675	1	CbGaD
Fosaprepitant—TACR1—vagus nerve—asthma	0.0272	0.603	CbGeAlD
Fosaprepitant—TACR1—respiratory system—asthma	0.00486	0.108	CbGeAlD
Fosaprepitant—Aprepitant—TACR1—asthma	0.00462	1	CrCbGaD
Fosaprepitant—TACR1—smooth muscle tissue—asthma	0.00392	0.0868	CbGeAlD
Fosaprepitant—TACR1—trachea—asthma	0.00359	0.0796	CbGeAlD
Fosaprepitant—TACR1—adrenal gland—asthma	0.00295	0.0653	CbGeAlD
Fosaprepitant—TACR1—lung—asthma	0.00258	0.0572	CbGeAlD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—asthma	0.000247	0.0024	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—UTS2—asthma	0.000246	0.00239	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCL11—asthma	0.000246	0.00239	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—C5AR1—asthma	0.000246	0.00239	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—EDN1—asthma	0.000243	0.00236	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—CCL2—asthma	0.00024	0.00234	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—EDN1—asthma	0.00024	0.00233	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CCL5—asthma	0.000238	0.00232	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—EDNRB—asthma	0.000237	0.0023	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCR4—asthma	0.000235	0.00229	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—TAC1—asthma	0.000234	0.00228	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—NPS—asthma	0.000234	0.00228	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—C3AR1—asthma	0.000232	0.00225	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR1—asthma	0.00023	0.00224	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—asthma	0.00023	0.00223	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CYSLTR2—asthma	0.000223	0.00217	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—C5—asthma	0.000219	0.00213	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—asthma	0.000218	0.00211	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—RHOA—asthma	0.000216	0.0021	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—LTB4R—asthma	0.000215	0.00209	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PTGDR—asthma	0.000215	0.00209	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CCR5—asthma	0.000215	0.00209	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—C3AR1—asthma	0.00021	0.00204	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—asthma	0.00021	0.00204	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—C3—asthma	0.00021	0.00204	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IFNG—asthma	0.000204	0.00199	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CYSLTR2—asthma	0.000202	0.00197	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCR3—asthma	0.0002	0.00194	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—PTGS2—asthma	0.000196	0.0019	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—LTB4R—asthma	0.000196	0.0019	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCL22—asthma	0.000196	0.0019	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PTGDR—asthma	0.000196	0.0019	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—NPY—asthma	0.000195	0.0019	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—IL6R—asthma	0.000192	0.00186	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—KNG1—asthma	0.000191	0.00186	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—AGTR1—asthma	0.00019	0.00185	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—CXCL8—asthma	0.00019	0.00185	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—AGTR2—asthma	0.000188	0.00183	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—asthma	0.000186	0.0018	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PTGDR2—asthma	0.000183	0.00178	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PMCH—asthma	0.000183	0.00178	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—NPSR1—asthma	0.000183	0.00178	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—HRH4—asthma	0.000183	0.00178	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IL1B—asthma	0.000182	0.00177	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IL2—asthma	0.000182	0.00176	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—asthma	0.00018	0.00175	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—EDNRB—asthma	0.00018	0.00175	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CSF2RB—asthma	0.000179	0.00174	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—NPS—asthma	0.000178	0.00173	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—TAC1—asthma	0.000178	0.00173	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—TACR2—asthma	0.000176	0.00171	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CCR8—asthma	0.000176	0.00171	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CXCR3—asthma	0.000175	0.0017	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—MMP9—asthma	0.000172	0.00167	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—POMC—asthma	0.000168	0.00163	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PMCH—asthma	0.000166	0.00162	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—HRH4—asthma	0.000166	0.00162	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—NPSR1—asthma	0.000166	0.00162	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PTGDR2—asthma	0.000166	0.00162	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CCL2—asthma	0.000164	0.0016	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CSF2RB—asthma	0.000163	0.00158	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—EDN1—asthma	0.000161	0.00157	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—BDKRB2—asthma	0.00016	0.00155	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL5—asthma	0.00016	0.00155	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—TACR2—asthma	0.000159	0.00155	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCR8—asthma	0.000159	0.00155	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCL17—asthma	0.000156	0.00152	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PDE4A—asthma	0.000153	0.00149	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—CXCL8—asthma	0.000152	0.00148	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—asthma	0.000148	0.00144	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—IL1B—asthma	0.000146	0.00142	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—KNG1—asthma	0.000146	0.00141	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—AGTR1—asthma	0.000145	0.00141	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCR5—asthma	0.000144	0.0014	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CYSLTR1—asthma	0.000144	0.0014	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—TGFB1—asthma	0.000142	0.00138	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CXCL10—asthma	0.000141	0.00137	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—C3—asthma	0.000141	0.00137	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PDE4A—asthma	0.000139	0.00135	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—EGFR—asthma	0.000139	0.00135	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—VIP—asthma	0.000139	0.00135	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—C5AR1—asthma	0.000139	0.00135	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—UTS2—asthma	0.000139	0.00135	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—ADRB2—asthma	0.000137	0.00133	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CCR4—asthma	0.000133	0.00129	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—TNF—asthma	0.000132	0.00129	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CYSLTR1—asthma	0.00013	0.00127	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CXCL8—asthma	0.00013	0.00126	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—IL2RB—asthma	0.000128	0.00124	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PDE4D—asthma	0.000127	0.00123	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—UTS2—asthma	0.000126	0.00122	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCL11—asthma	0.000126	0.00122	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—C5AR1—asthma	0.000126	0.00122	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—VIP—asthma	0.000126	0.00122	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—FCER2—asthma	0.000124	0.00121	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—C3AR1—asthma	0.000124	0.00121	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—C5—asthma	0.000124	0.0012	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PDE4B—asthma	0.000124	0.0012	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—VEGFA—asthma	0.000123	0.0012	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—EDN1—asthma	0.000123	0.00119	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCL5—asthma	0.000122	0.00118	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCR4—asthma	0.000121	0.00117	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CYSLTR2—asthma	0.00012	0.00116	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—IL2RB—asthma	0.000116	0.00113	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCL22—asthma	0.000116	0.00112	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PTGDR—asthma	0.000116	0.00112	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—LTB4R—asthma	0.000116	0.00112	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PDE4D—asthma	0.000115	0.00112	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CCR3—asthma	0.000113	0.0011	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—POMC—asthma	0.000113	0.00109	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PDE4B—asthma	0.000112	0.00109	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—C5—asthma	0.000112	0.00109	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—NPY—asthma	0.00011	0.00107	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL2—asthma	0.00011	0.00107	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCR5—asthma	0.00011	0.00107	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—C3—asthma	0.000107	0.00104	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IL6—asthma	0.000107	0.00104	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—AGTR2—asthma	0.000106	0.00103	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—TNF—asthma	0.000106	0.00103	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCR3—asthma	0.000103	0.000998	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—EDNRB—asthma	0.000102	0.00099	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—NPS—asthma	0.000101	0.00098	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—TAC1—asthma	0.000101	0.00098	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—NPY—asthma	0.0001	0.000973	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CXCR3—asthma	9.89e-05	0.000961	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NPSR1—asthma	9.82e-05	0.000954	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HRH4—asthma	9.82e-05	0.000954	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PMCH—asthma	9.82e-05	0.000954	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PTGDR2—asthma	9.82e-05	0.000954	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—AGTR2—asthma	9.66e-05	0.000938	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CSF2RB—asthma	9.61e-05	0.000934	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCR8—asthma	9.42e-05	0.000915	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TACR2—asthma	9.42e-05	0.000915	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—IL5—asthma	9.37e-05	0.000911	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—EDNRB—asthma	9.25e-05	0.000899	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCL17—asthma	9.24e-05	0.000897	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—NPS—asthma	9.16e-05	0.00089	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—TAC1—asthma	9.16e-05	0.00089	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—BDKRB2—asthma	9.04e-05	0.000879	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CXCR3—asthma	8.98e-05	0.000872	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—ADCY2—asthma	8.75e-05	0.00085	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—IL3—asthma	8.72e-05	0.000847	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—asthma	8.71e-05	0.000846	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—asthma	8.6e-05	0.000835	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—POMC—asthma	8.57e-05	0.000833	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—IL6—asthma	8.54e-05	0.00083	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—IL5—asthma	8.51e-05	0.000827	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCL2—asthma	8.39e-05	0.000815	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—KIF3A—asthma	8.23e-05	0.0008	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PDE4A—asthma	8.23e-05	0.0008	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—KNG1—asthma	8.23e-05	0.000799	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—BDKRB2—asthma	8.21e-05	0.000798	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—AGTR1—asthma	8.18e-05	0.000795	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CXCL10—asthma	7.99e-05	0.000777	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—ADCY2—asthma	7.95e-05	0.000772	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—IL3—asthma	7.92e-05	0.000769	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—ADRB2—asthma	7.76e-05	0.000754	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CYSLTR1—asthma	7.71e-05	0.000749	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—KNG1—asthma	7.47e-05	0.000726	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CMA1—asthma	7.44e-05	0.000723	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCL11—asthma	7.44e-05	0.000723	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—C5AR1—asthma	7.44e-05	0.000723	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—UTS2—asthma	7.44e-05	0.000723	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—VIP—asthma	7.44e-05	0.000723	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—AGTR1—asthma	7.43e-05	0.000722	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—ITPR1—asthma	7.34e-05	0.000713	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CXCL10—asthma	7.26e-05	0.000705	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCR4—asthma	7.14e-05	0.000693	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—ADRB2—asthma	7.05e-05	0.000685	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—STAT6—asthma	7e-05	0.00068	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—EDN1—asthma	6.93e-05	0.000674	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CCL5—asthma	6.88e-05	0.000668	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IL2RB—asthma	6.87e-05	0.000667	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PDE4D—asthma	6.81e-05	0.000662	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CSF2—asthma	6.78e-05	0.000658	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—ITPR1—asthma	6.66e-05	0.000648	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—C5—asthma	6.63e-05	0.000645	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PDE4B—asthma	6.63e-05	0.000645	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CXCL8—asthma	6.63e-05	0.000644	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—asthma	6.61e-05	0.000642	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—EDN1—asthma	6.3e-05	0.000612	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCL5—asthma	6.25e-05	0.000607	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PLA2G4A—asthma	6.22e-05	0.000605	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CCR5—asthma	6.2e-05	0.000602	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CSF2—asthma	6.15e-05	0.000598	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—IL2RA—asthma	6.11e-05	0.000594	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCR3—asthma	6.07e-05	0.00059	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—C3—asthma	6.06e-05	0.000589	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NPY—asthma	5.91e-05	0.000575	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PPP2CA—asthma	5.73e-05	0.000557	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—AGTR2—asthma	5.71e-05	0.000554	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCR5—asthma	5.63e-05	0.000547	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—IL2RA—asthma	5.55e-05	0.000539	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—C3—asthma	5.5e-05	0.000534	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—EDNRB—asthma	5.46e-05	0.000531	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TAC1—asthma	5.41e-05	0.000526	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NPS—asthma	5.41e-05	0.000526	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CXCR3—asthma	5.3e-05	0.000515	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CYBA—asthma	5.14e-05	0.000499	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PARP1—asthma	5.03e-05	0.000489	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IL5—asthma	5.03e-05	0.000489	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—BDKRB2—asthma	4.85e-05	0.000471	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—POMC—asthma	4.84e-05	0.000471	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—ADCY2—asthma	4.69e-05	0.000456	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IL3—asthma	4.68e-05	0.000455	CbGpPWpGaD
Fosaprepitant—Eye disorder—Dexamethasone—asthma	4.65e-05	0.00027	CcSEcCtD
Fosaprepitant—Eye disorder—Betamethasone—asthma	4.65e-05	0.00027	CcSEcCtD
Fosaprepitant—Nausea—Arformoterol—asthma	4.64e-05	0.00027	CcSEcCtD
Fosaprepitant—Nausea—Formoterol—asthma	4.64e-05	0.00027	CcSEcCtD
Fosaprepitant—Angioedema—Hydrocortisone—asthma	4.63e-05	0.000269	CcSEcCtD
Fosaprepitant—Headache—Salbutamol—asthma	4.63e-05	0.000269	CcSEcCtD
Fosaprepitant—Malaise—Hydrocortisone—asthma	4.57e-05	0.000266	CcSEcCtD
Fosaprepitant—Loss of consciousness—Prednisolone—asthma	4.56e-05	0.000265	CcSEcCtD
Fosaprepitant—Nausea—Montelukast—asthma	4.55e-05	0.000265	CcSEcCtD
Fosaprepitant—Vomiting—Budesonide—asthma	4.55e-05	0.000264	CcSEcCtD
Fosaprepitant—Syncope—Hydrocortisone—asthma	4.54e-05	0.000264	CcSEcCtD
Fosaprepitant—Angiopathy—Betamethasone—asthma	4.51e-05	0.000262	CcSEcCtD
Fosaprepitant—Angiopathy—Dexamethasone—asthma	4.51e-05	0.000262	CcSEcCtD
Fosaprepitant—Rash—Budesonide—asthma	4.51e-05	0.000262	CcSEcCtD
Fosaprepitant—Dermatitis—Budesonide—asthma	4.51e-05	0.000262	CcSEcCtD
Fosaprepitant—Headache—Budesonide—asthma	4.48e-05	0.000261	CcSEcCtD
Fosaprepitant—Hypertension—Prednisolone—asthma	4.48e-05	0.000261	CcSEcCtD
Fosaprepitant—Loss of consciousness—Hydrocortisone—asthma	4.45e-05	0.000259	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Triamcinolone—asthma	4.43e-05	0.000257	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Methylprednisolone—asthma	4.42e-05	0.000257	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—KNG1—asthma	4.41e-05	0.000429	CbGpPWpGaD
Fosaprepitant—Bradycardia—Prednisone—asthma	4.41e-05	0.000256	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—POMC—asthma	4.4e-05	0.000427	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—AGTR1—asthma	4.39e-05	0.000426	CbGpPWpGaD
Fosaprepitant—Nausea—Salbutamol—asthma	4.39e-05	0.000255	CcSEcCtD
Fosaprepitant—Hypertension—Hydrocortisone—asthma	4.38e-05	0.000254	CcSEcCtD
Fosaprepitant—Discomfort—Prednisolone—asthma	4.36e-05	0.000254	CcSEcCtD
Fosaprepitant—Angioedema—Triamcinolone—asthma	4.36e-05	0.000254	CcSEcCtD
Fosaprepitant—Angioedema—Methylprednisolone—asthma	4.35e-05	0.000253	CcSEcCtD
Fosaprepitant—Erythema—Dexamethasone—asthma	4.33e-05	0.000252	CcSEcCtD
Fosaprepitant—Erythema—Betamethasone—asthma	4.33e-05	0.000252	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—CCL2—asthma	4.3e-05	0.000418	CbGpPWpGaD
Fosaprepitant—Malaise—Triamcinolone—asthma	4.3e-05	0.00025	CcSEcCtD
Fosaprepitant—Anxiety—Hydrocortisone—asthma	4.3e-05	0.00025	CcSEcCtD
Fosaprepitant—Malaise—Methylprednisolone—asthma	4.29e-05	0.00025	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—IL6R—asthma	4.29e-05	0.000417	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CXCL10—asthma	4.29e-05	0.000417	CbGpPWpGaD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	4.28e-05	0.000249	CcSEcCtD
Fosaprepitant—Syncope—Triamcinolone—asthma	4.28e-05	0.000249	CcSEcCtD
Fosaprepitant—Syncope—Methylprednisolone—asthma	4.27e-05	0.000248	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—RHOA—asthma	4.27e-05	0.000415	CbGpPWpGaD
Fosaprepitant—Discomfort—Hydrocortisone—asthma	4.26e-05	0.000248	CcSEcCtD
Fosaprepitant—Connective tissue disorder—Prednisone—asthma	4.26e-05	0.000248	CcSEcCtD
Fosaprepitant—Nausea—Budesonide—asthma	4.25e-05	0.000247	CcSEcCtD
Fosaprepitant—Oedema—Prednisolone—asthma	4.23e-05	0.000246	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Prednisolone—asthma	4.23e-05	0.000246	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—NTRK1—asthma	4.21e-05	0.000409	CbGpPWpGaD
Fosaprepitant—Loss of consciousness—Triamcinolone—asthma	4.19e-05	0.000244	CcSEcCtD
Fosaprepitant—Loss of consciousness—Methylprednisolone—asthma	4.18e-05	0.000243	CcSEcCtD
Fosaprepitant—Shock—Prednisolone—asthma	4.17e-05	0.000242	CcSEcCtD
Fosaprepitant—Cough—Triamcinolone—asthma	4.16e-05	0.000242	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—ADRB2—asthma	4.16e-05	0.000404	CbGpPWpGaD
Fosaprepitant—Oedema—Hydrocortisone—asthma	4.14e-05	0.000241	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Hydrocortisone—asthma	4.14e-05	0.000241	CcSEcCtD
Fosaprepitant—Hypertension—Triamcinolone—asthma	4.12e-05	0.00024	CcSEcCtD
Fosaprepitant—Hypertension—Methylprednisolone—asthma	4.11e-05	0.000239	CcSEcCtD
Fosaprepitant—Infection—Hydrocortisone—asthma	4.11e-05	0.000239	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Prednisolone—asthma	4.09e-05	0.000238	CcSEcCtD
Fosaprepitant—Shock—Hydrocortisone—asthma	4.07e-05	0.000237	CcSEcCtD
Fosaprepitant—Nervous system disorder—Hydrocortisone—asthma	4.06e-05	0.000236	CcSEcCtD
Fosaprepitant—Eye disorder—Prednisone—asthma	4.05e-05	0.000235	CcSEcCtD
Fosaprepitant—Anxiety—Methylprednisolone—asthma	4.04e-05	0.000235	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	4.03e-05	0.000234	CcSEcCtD
Fosaprepitant—Flushing—Prednisone—asthma	4.02e-05	0.000234	CcSEcCtD
Fosaprepitant—Skin disorder—Hydrocortisone—asthma	4.02e-05	0.000234	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Betamethasone—asthma	4.02e-05	0.000234	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Dexamethasone—asthma	4.02e-05	0.000234	CcSEcCtD
Fosaprepitant—Discomfort—Triamcinolone—asthma	4.01e-05	0.000233	CcSEcCtD
Fosaprepitant—Discomfort—Methylprednisolone—asthma	4e-05	0.000233	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Hydrocortisone—asthma	4e-05	0.000233	CcSEcCtD
Fosaprepitant—Dry mouth—Triamcinolone—asthma	3.97e-05	0.000231	CcSEcCtD
Fosaprepitant—Angioedema—Dexamethasone—asthma	3.96e-05	0.00023	CcSEcCtD
Fosaprepitant—Angioedema—Betamethasone—asthma	3.96e-05	0.00023	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—ITPR1—asthma	3.94e-05	0.000383	CbGpPWpGaD
Fosaprepitant—Angiopathy—Prednisone—asthma	3.93e-05	0.000229	CcSEcCtD
Fosaprepitant—Immune system disorder—Prednisone—asthma	3.91e-05	0.000228	CcSEcCtD
Fosaprepitant—Malaise—Betamethasone—asthma	3.9e-05	0.000227	CcSEcCtD
Fosaprepitant—Malaise—Dexamethasone—asthma	3.9e-05	0.000227	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Triamcinolone—asthma	3.89e-05	0.000226	CcSEcCtD
Fosaprepitant—Oedema—Triamcinolone—asthma	3.89e-05	0.000226	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Methylprednisolone—asthma	3.89e-05	0.000226	CcSEcCtD
Fosaprepitant—Syncope—Betamethasone—asthma	3.88e-05	0.000226	CcSEcCtD
Fosaprepitant—Syncope—Dexamethasone—asthma	3.88e-05	0.000226	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—RHOA—asthma	3.88e-05	0.000377	CbGpPWpGaD
Fosaprepitant—Infection—Triamcinolone—asthma	3.87e-05	0.000225	CcSEcCtD
Fosaprepitant—Hypotension—Hydrocortisone—asthma	3.86e-05	0.000225	CcSEcCtD
Fosaprepitant—Infection—Methylprednisolone—asthma	3.86e-05	0.000224	CcSEcCtD
Fosaprepitant—Shock—Triamcinolone—asthma	3.83e-05	0.000223	CcSEcCtD
Fosaprepitant—Insomnia—Prednisolone—asthma	3.83e-05	0.000223	CcSEcCtD
Fosaprepitant—Shock—Methylprednisolone—asthma	3.82e-05	0.000222	CcSEcCtD
Fosaprepitant—Nervous system disorder—Methylprednisolone—asthma	3.81e-05	0.000222	CcSEcCtD
Fosaprepitant—Loss of consciousness—Dexamethasone—asthma	3.81e-05	0.000221	CcSEcCtD
Fosaprepitant—Loss of consciousness—Betamethasone—asthma	3.81e-05	0.000221	CcSEcCtD
Fosaprepitant—Mental disorder—Prednisone—asthma	3.79e-05	0.000221	CcSEcCtD
Fosaprepitant—Skin disorder—Methylprednisolone—asthma	3.77e-05	0.000219	CcSEcCtD
Fosaprepitant—Malnutrition—Prednisone—asthma	3.77e-05	0.000219	CcSEcCtD
Fosaprepitant—Erythema—Prednisone—asthma	3.77e-05	0.000219	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Triamcinolone—asthma	3.76e-05	0.000219	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Methylprednisolone—asthma	3.76e-05	0.000218	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CD86—asthma	3.75e-05	0.000364	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CXCL8—asthma	3.75e-05	0.000364	CbGpPWpGaD
Fosaprepitant—Insomnia—Hydrocortisone—asthma	3.74e-05	0.000218	CcSEcCtD
Fosaprepitant—Hypertension—Betamethasone—asthma	3.74e-05	0.000217	CcSEcCtD
Fosaprepitant—Hypertension—Dexamethasone—asthma	3.74e-05	0.000217	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—EDN1—asthma	3.72e-05	0.000361	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCL5—asthma	3.69e-05	0.000359	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PLA2G4A—asthma	3.68e-05	0.000357	CbGpPWpGaD
Fosaprepitant—Anxiety—Dexamethasone—asthma	3.67e-05	0.000214	CcSEcCtD
Fosaprepitant—Anxiety—Betamethasone—asthma	3.67e-05	0.000214	CcSEcCtD
Fosaprepitant—Discomfort—Dexamethasone—asthma	3.64e-05	0.000212	CcSEcCtD
Fosaprepitant—Discomfort—Betamethasone—asthma	3.64e-05	0.000212	CcSEcCtD
Fosaprepitant—Dyspepsia—Hydrocortisone—asthma	3.64e-05	0.000212	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CSF2—asthma	3.64e-05	0.000353	CbGpPWpGaD
Fosaprepitant—Hypotension—Methylprednisolone—asthma	3.63e-05	0.000211	CcSEcCtD
Fosaprepitant—Pain—Prednisolone—asthma	3.62e-05	0.000211	CcSEcCtD
Fosaprepitant—Decreased appetite—Hydrocortisone—asthma	3.6e-05	0.000209	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—IL2—asthma	3.58e-05	0.000348	CbGpPWpGaD
Fosaprepitant—Gastrointestinal disorder—Hydrocortisone—asthma	3.57e-05	0.000208	CcSEcCtD
Fosaprepitant—Fatigue—Hydrocortisone—asthma	3.57e-05	0.000207	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—SMAD3—asthma	3.54e-05	0.000344	CbGpPWpGaD
Fosaprepitant—Pain—Hydrocortisone—asthma	3.54e-05	0.000206	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Betamethasone—asthma	3.53e-05	0.000205	CcSEcCtD
Fosaprepitant—Oedema—Betamethasone—asthma	3.53e-05	0.000205	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Dexamethasone—asthma	3.53e-05	0.000205	CcSEcCtD
Fosaprepitant—Oedema—Dexamethasone—asthma	3.53e-05	0.000205	CcSEcCtD
Fosaprepitant—Insomnia—Triamcinolone—asthma	3.52e-05	0.000205	CcSEcCtD
Fosaprepitant—Insomnia—Methylprednisolone—asthma	3.51e-05	0.000204	CcSEcCtD
Fosaprepitant—Infection—Dexamethasone—asthma	3.51e-05	0.000204	CcSEcCtD
Fosaprepitant—Infection—Betamethasone—asthma	3.51e-05	0.000204	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Prednisone—asthma	3.5e-05	0.000203	CcSEcCtD
Fosaprepitant—Feeling abnormal—Prednisolone—asthma	3.49e-05	0.000203	CcSEcCtD
Fosaprepitant—Anaemia—Prednisone—asthma	3.49e-05	0.000203	CcSEcCtD
Fosaprepitant—Shock—Dexamethasone—asthma	3.48e-05	0.000202	CcSEcCtD
Fosaprepitant—Shock—Betamethasone—asthma	3.48e-05	0.000202	CcSEcCtD
Fosaprepitant—Dyspnoea—Triamcinolone—asthma	3.47e-05	0.000202	CcSEcCtD
Fosaprepitant—Nervous system disorder—Betamethasone—asthma	3.47e-05	0.000202	CcSEcCtD
Fosaprepitant—Nervous system disorder—Dexamethasone—asthma	3.47e-05	0.000202	CcSEcCtD
Fosaprepitant—Angioedema—Prednisone—asthma	3.45e-05	0.0002	CcSEcCtD
Fosaprepitant—Dyspepsia—Triamcinolone—asthma	3.43e-05	0.000199	CcSEcCtD
Fosaprepitant—Dyspepsia—Methylprednisolone—asthma	3.42e-05	0.000199	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Betamethasone—asthma	3.42e-05	0.000199	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Dexamethasone—asthma	3.42e-05	0.000199	CcSEcCtD
Fosaprepitant—Feeling abnormal—Hydrocortisone—asthma	3.41e-05	0.000198	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—CXCL8—asthma	3.4e-05	0.000331	CbGpPWpGaD
Fosaprepitant—Malaise—Prednisone—asthma	3.4e-05	0.000198	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—PPP2CA—asthma	3.39e-05	0.000329	CbGpPWpGaD
Fosaprepitant—Gastrointestinal pain—Hydrocortisone—asthma	3.38e-05	0.000197	CcSEcCtD
Fosaprepitant—Syncope—Prednisone—asthma	3.38e-05	0.000197	CcSEcCtD
Fosaprepitant—Urticaria—Prednisolone—asthma	3.36e-05	0.000196	CcSEcCtD
Fosaprepitant—Fatigue—Triamcinolone—asthma	3.36e-05	0.000195	CcSEcCtD
Fosaprepitant—Fatigue—Methylprednisolone—asthma	3.35e-05	0.000195	CcSEcCtD
Fosaprepitant—Pain—Triamcinolone—asthma	3.33e-05	0.000194	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CCR5—asthma	3.32e-05	0.000323	CbGpPWpGaD
Fosaprepitant—Loss of consciousness—Prednisone—asthma	3.31e-05	0.000193	CcSEcCtD
Fosaprepitant—Hypotension—Betamethasone—asthma	3.3e-05	0.000192	CcSEcCtD
Fosaprepitant—Hypotension—Dexamethasone—asthma	3.3e-05	0.000192	CcSEcCtD
Fosaprepitant—Urticaria—Hydrocortisone—asthma	3.29e-05	0.000191	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—IL2RA—asthma	3.28e-05	0.000318	CbGpPWpGaD
Fosaprepitant—Body temperature increased—Hydrocortisone—asthma	3.27e-05	0.00019	CcSEcCtD
Fosaprepitant—Abdominal pain—Hydrocortisone—asthma	3.27e-05	0.00019	CcSEcCtD
Fosaprepitant—Hypertension—Prednisone—asthma	3.26e-05	0.000189	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—IL2—asthma	3.25e-05	0.000316	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—C3—asthma	3.25e-05	0.000316	CbGpPWpGaD
Fosaprepitant—Feeling abnormal—Triamcinolone—asthma	3.21e-05	0.000187	CcSEcCtD
Fosaprepitant—Feeling abnormal—Methylprednisolone—asthma	3.2e-05	0.000186	CcSEcCtD
Fosaprepitant—Anxiety—Prednisone—asthma	3.2e-05	0.000186	CcSEcCtD
Fosaprepitant—Insomnia—Betamethasone—asthma	3.2e-05	0.000186	CcSEcCtD
Fosaprepitant—Insomnia—Dexamethasone—asthma	3.2e-05	0.000186	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	3.19e-05	0.000185	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Methylprednisolone—asthma	3.18e-05	0.000185	CcSEcCtD
Fosaprepitant—Discomfort—Prednisone—asthma	3.17e-05	0.000184	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—PDGFB—asthma	3.16e-05	0.000307	CbGpPWpGaD
Fosaprepitant—Hypersensitivity—Prednisolone—asthma	3.12e-05	0.000181	CcSEcCtD
Fosaprepitant—Dyspepsia—Betamethasone—asthma	3.11e-05	0.000181	CcSEcCtD
Fosaprepitant—Dyspepsia—Dexamethasone—asthma	3.11e-05	0.000181	CcSEcCtD
Fosaprepitant—Urticaria—Triamcinolone—asthma	3.09e-05	0.00018	CcSEcCtD
Fosaprepitant—Urticaria—Methylprednisolone—asthma	3.09e-05	0.00018	CcSEcCtD
Fosaprepitant—Body temperature increased—Triamcinolone—asthma	3.08e-05	0.000179	CcSEcCtD
Fosaprepitant—Oedema—Prednisone—asthma	3.08e-05	0.000179	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Prednisone—asthma	3.08e-05	0.000179	CcSEcCtD
Fosaprepitant—Abdominal pain—Methylprednisolone—asthma	3.07e-05	0.000179	CcSEcCtD
Fosaprepitant—Decreased appetite—Dexamethasone—asthma	3.07e-05	0.000179	CcSEcCtD
Fosaprepitant—Decreased appetite—Betamethasone—asthma	3.07e-05	0.000179	CcSEcCtD
Fosaprepitant—Infection—Prednisone—asthma	3.06e-05	0.000178	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Betamethasone—asthma	3.05e-05	0.000177	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Dexamethasone—asthma	3.05e-05	0.000177	CcSEcCtD
Fosaprepitant—Hypersensitivity—Hydrocortisone—asthma	3.05e-05	0.000177	CcSEcCtD
Fosaprepitant—Fatigue—Betamethasone—asthma	3.05e-05	0.000177	CcSEcCtD
Fosaprepitant—Fatigue—Dexamethasone—asthma	3.05e-05	0.000177	CcSEcCtD
Fosaprepitant—Shock—Prednisone—asthma	3.03e-05	0.000176	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—LEP—asthma	3.02e-05	0.000294	CbGpPWpGaD
Fosaprepitant—Pain—Dexamethasone—asthma	3.02e-05	0.000176	CcSEcCtD
Fosaprepitant—Pain—Betamethasone—asthma	3.02e-05	0.000176	CcSEcCtD
Fosaprepitant—Nervous system disorder—Prednisone—asthma	3.02e-05	0.000175	CcSEcCtD
Fosaprepitant—Skin disorder—Prednisone—asthma	2.99e-05	0.000174	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Prednisone—asthma	2.97e-05	0.000173	CcSEcCtD
Fosaprepitant—Asthenia—Hydrocortisone—asthma	2.97e-05	0.000173	CcSEcCtD
Fosaprepitant—Pruritus—Hydrocortisone—asthma	2.93e-05	0.00017	CcSEcCtD
Fosaprepitant—Feeling abnormal—Dexamethasone—asthma	2.91e-05	0.000169	CcSEcCtD
Fosaprepitant—Feeling abnormal—Betamethasone—asthma	2.91e-05	0.000169	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Betamethasone—asthma	2.89e-05	0.000168	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Dexamethasone—asthma	2.89e-05	0.000168	CcSEcCtD
Fosaprepitant—Hypersensitivity—Triamcinolone—asthma	2.87e-05	0.000167	CcSEcCtD
Fosaprepitant—Hypersensitivity—Methylprednisolone—asthma	2.86e-05	0.000166	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—FN1—asthma	2.85e-05	0.000277	CbGpPWpGaD
Fosaprepitant—Diarrhoea—Hydrocortisone—asthma	2.83e-05	0.000165	CcSEcCtD
Fosaprepitant—Urticaria—Betamethasone—asthma	2.81e-05	0.000163	CcSEcCtD
Fosaprepitant—Urticaria—Dexamethasone—asthma	2.81e-05	0.000163	CcSEcCtD
Fosaprepitant—Dizziness—Prednisolone—asthma	2.8e-05	0.000163	CcSEcCtD
Fosaprepitant—Asthenia—Triamcinolone—asthma	2.79e-05	0.000162	CcSEcCtD
Fosaprepitant—Body temperature increased—Betamethasone—asthma	2.79e-05	0.000162	CcSEcCtD
Fosaprepitant—Abdominal pain—Dexamethasone—asthma	2.79e-05	0.000162	CcSEcCtD
Fosaprepitant—Abdominal pain—Betamethasone—asthma	2.79e-05	0.000162	CcSEcCtD
Fosaprepitant—Body temperature increased—Dexamethasone—asthma	2.79e-05	0.000162	CcSEcCtD
Fosaprepitant—Asthenia—Methylprednisolone—asthma	2.79e-05	0.000162	CcSEcCtD
Fosaprepitant—Insomnia—Prednisone—asthma	2.78e-05	0.000162	CcSEcCtD
Fosaprepitant—Pruritus—Triamcinolone—asthma	2.76e-05	0.00016	CcSEcCtD
Fosaprepitant—Pruritus—Methylprednisolone—asthma	2.75e-05	0.00016	CcSEcCtD
Fosaprepitant—Dizziness—Hydrocortisone—asthma	2.74e-05	0.000159	CcSEcCtD
Fosaprepitant—Dyspepsia—Prednisone—asthma	2.71e-05	0.000158	CcSEcCtD
Fosaprepitant—Decreased appetite—Prednisone—asthma	2.68e-05	0.000156	CcSEcCtD
Fosaprepitant—Rash—Prednisolone—asthma	2.67e-05	0.000155	CcSEcCtD
Fosaprepitant—Dermatitis—Prednisolone—asthma	2.67e-05	0.000155	CcSEcCtD
Fosaprepitant—Diarrhoea—Methylprednisolone—asthma	2.66e-05	0.000155	CcSEcCtD
Fosaprepitant—Fatigue—Prednisone—asthma	2.65e-05	0.000154	CcSEcCtD
Fosaprepitant—Headache—Prednisolone—asthma	2.65e-05	0.000154	CcSEcCtD
Fosaprepitant—Constipation—Prednisone—asthma	2.63e-05	0.000153	CcSEcCtD
Fosaprepitant—Vomiting—Hydrocortisone—asthma	2.63e-05	0.000153	CcSEcCtD
Fosaprepitant—Rash—Hydrocortisone—asthma	2.61e-05	0.000152	CcSEcCtD
Fosaprepitant—Dermatitis—Hydrocortisone—asthma	2.61e-05	0.000152	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—POMC—asthma	2.6e-05	0.000252	CbGpPWpGaD
Fosaprepitant—Headache—Hydrocortisone—asthma	2.59e-05	0.000151	CcSEcCtD
Fosaprepitant—Dizziness—Triamcinolone—asthma	2.58e-05	0.00015	CcSEcCtD
Fosaprepitant—Dizziness—Methylprednisolone—asthma	2.57e-05	0.000149	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CCL2—asthma	2.54e-05	0.000247	CbGpPWpGaD
Fosaprepitant—Feeling abnormal—Prednisone—asthma	2.54e-05	0.000147	CcSEcCtD
Fosaprepitant—Asthenia—Dexamethasone—asthma	2.54e-05	0.000147	CcSEcCtD
Fosaprepitant—Asthenia—Betamethasone—asthma	2.54e-05	0.000147	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—IL6R—asthma	2.53e-05	0.000246	CbGpPWpGaD
Fosaprepitant—Gastrointestinal pain—Prednisone—asthma	2.52e-05	0.000146	CcSEcCtD
Fosaprepitant—Nausea—Prednisolone—asthma	2.52e-05	0.000146	CcSEcCtD
Fosaprepitant—Pruritus—Dexamethasone—asthma	2.5e-05	0.000145	CcSEcCtD
Fosaprepitant—Pruritus—Betamethasone—asthma	2.5e-05	0.000145	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—EGFR—asthma	2.49e-05	0.000242	CbGpPWpGaD
Fosaprepitant—Vomiting—Triamcinolone—asthma	2.48e-05	0.000144	CcSEcCtD
Fosaprepitant—Vomiting—Methylprednisolone—asthma	2.47e-05	0.000144	CcSEcCtD
Fosaprepitant—Nausea—Hydrocortisone—asthma	2.46e-05	0.000143	CcSEcCtD
Fosaprepitant—Rash—Triamcinolone—asthma	2.46e-05	0.000143	CcSEcCtD
Fosaprepitant—Dermatitis—Triamcinolone—asthma	2.45e-05	0.000143	CcSEcCtD
Fosaprepitant—Rash—Methylprednisolone—asthma	2.45e-05	0.000142	CcSEcCtD
Fosaprepitant—Dermatitis—Methylprednisolone—asthma	2.45e-05	0.000142	CcSEcCtD
Fosaprepitant—Urticaria—Prednisone—asthma	2.44e-05	0.000142	CcSEcCtD
Fosaprepitant—Headache—Triamcinolone—asthma	2.44e-05	0.000142	CcSEcCtD
Fosaprepitant—Headache—Methylprednisolone—asthma	2.43e-05	0.000142	CcSEcCtD
Fosaprepitant—Body temperature increased—Prednisone—asthma	2.43e-05	0.000141	CcSEcCtD
Fosaprepitant—Abdominal pain—Prednisone—asthma	2.43e-05	0.000141	CcSEcCtD
Fosaprepitant—Diarrhoea—Betamethasone—asthma	2.42e-05	0.000141	CcSEcCtD
Fosaprepitant—Diarrhoea—Dexamethasone—asthma	2.42e-05	0.000141	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—SERPINE1—asthma	2.37e-05	0.000231	CbGpPWpGaD
Fosaprepitant—Dizziness—Betamethasone—asthma	2.34e-05	0.000136	CcSEcCtD
Fosaprepitant—Dizziness—Dexamethasone—asthma	2.34e-05	0.000136	CcSEcCtD
Fosaprepitant—Nausea—Triamcinolone—asthma	2.31e-05	0.000135	CcSEcCtD
Fosaprepitant—Nausea—Methylprednisolone—asthma	2.31e-05	0.000134	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—RHOA—asthma	2.29e-05	0.000222	CbGpPWpGaD
Fosaprepitant—Hypersensitivity—Prednisone—asthma	2.27e-05	0.000132	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—NOS3—asthma	2.27e-05	0.00022	CbGpPWpGaD
Fosaprepitant—Vomiting—Betamethasone—asthma	2.25e-05	0.000131	CcSEcCtD
Fosaprepitant—Vomiting—Dexamethasone—asthma	2.25e-05	0.000131	CcSEcCtD
Fosaprepitant—Rash—Dexamethasone—asthma	2.23e-05	0.00013	CcSEcCtD
Fosaprepitant—Rash—Betamethasone—asthma	2.23e-05	0.00013	CcSEcCtD
Fosaprepitant—Dermatitis—Betamethasone—asthma	2.23e-05	0.000129	CcSEcCtD
Fosaprepitant—Dermatitis—Dexamethasone—asthma	2.23e-05	0.000129	CcSEcCtD
Fosaprepitant—Headache—Betamethasone—asthma	2.21e-05	0.000129	CcSEcCtD
Fosaprepitant—Headache—Dexamethasone—asthma	2.21e-05	0.000129	CcSEcCtD
Fosaprepitant—Asthenia—Prednisone—asthma	2.21e-05	0.000128	CcSEcCtD
Fosaprepitant—Pruritus—Prednisone—asthma	2.18e-05	0.000127	CcSEcCtD
Fosaprepitant—Diarrhoea—Prednisone—asthma	2.11e-05	0.000122	CcSEcCtD
Fosaprepitant—Nausea—Betamethasone—asthma	2.1e-05	0.000122	CcSEcCtD
Fosaprepitant—Nausea—Dexamethasone—asthma	2.1e-05	0.000122	CcSEcCtD
Fosaprepitant—Dizziness—Prednisone—asthma	2.04e-05	0.000118	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CXCL8—asthma	2.01e-05	0.000195	CbGpPWpGaD
Fosaprepitant—Vomiting—Prednisone—asthma	1.96e-05	0.000114	CcSEcCtD
Fosaprepitant—Rash—Prednisone—asthma	1.94e-05	0.000113	CcSEcCtD
Fosaprepitant—Dermatitis—Prednisone—asthma	1.94e-05	0.000113	CcSEcCtD
Fosaprepitant—Headache—Prednisone—asthma	1.93e-05	0.000112	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—IL2—asthma	1.92e-05	0.000187	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—IL6—asthma	1.91e-05	0.000186	CbGpPWpGaD
Fosaprepitant—Nausea—Prednisone—asthma	1.83e-05	0.000106	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—MMP9—asthma	1.82e-05	0.000177	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PTEN—asthma	1.81e-05	0.000176	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—VEGFA—asthma	1.63e-05	0.000159	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—STAT3—asthma	1.62e-05	0.000157	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TGFB1—asthma	1.5e-05	0.000146	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—EGFR—asthma	1.47e-05	0.000143	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IL6—asthma	1.13e-05	0.00011	CbGpPWpGaD
